In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.

Siegal, T; Rubinstein, R; Bokstein, F; Schwartz, A; Lossos, A; Shalom, E; Chisin, R; Gomori, J M

Siegal, T; Rubinstein, R; Bokstein, F; Schwartz, A; Lossos, A; Shalom, E; Chisin, R; Gomori, J M.

Affiliation

Siegal T; Department of Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. siegal@hadassah.org.il

J Neurosurg ; 92(4): 599-605, 2000 Apr.

Article in En | MEDLINE | ID: mdl-10761648

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Blood-Brain Barrier/drug effects; Brain Neoplasms/drug therapy; Diuretics, Osmotic/therapeutic use; Mannitol/therapeutic use; Adult; Aged; Brain/diagnostic imaging; Brain Neoplasms/diagnostic imaging; Contrast Media; Diuretics, Osmotic/administration & dosage; Female; Humans; Infusions, Intra-Arterial; Lymphoma/drug therapy; Male; Mannitol/administration & dosage; Middle Aged; Molecular Weight; Neuroectodermal Tumors/drug therapy; Organotechnetium Compounds; Osmosis; Permeability; Radiopharmaceuticals; Sugar Acids; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Blood-Brain Barrier / Antineoplastic Combined Chemotherapy Protocols / Diuretics, Osmotic / Mannitol Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurosurg Year: 2000 Document type: Article Affiliation country: Israel

Search on Google

Add to My VHL

XML

PubMed Links